https://www.selleckchem.com/pr....oducts/vu0463271.htm
mber of QALYs because of the disutility associated with the continuous treatment. Policy makers increasingly seek to complement data from clinical trials with information from routine care. This study aims to provide a detailed account of the hospital resource use and associated costs of patients with advanced breast cancer in The Netherlands. Data from 597 patients with advanced breast cancer, diagnosed between 2010 and 2014, were retrieved from the Southeast Netherlands Advanced Breast Cancer Registry. Database lock for this study w
Mi piace
Commento
Condividi
